Newsletter
Changing the Way We Monitor Immunotherapy with a Personalized Blood Test with Angel Rodriguez, Oncology Medical Director at Natera

Outcomes Rocket

Changing the Way We Monitor Immunotherapy with a Personalized Blood Test with Angel Rodriguez, Oncology Medical Director at Natera

April 20, 2022

Changing the Way We Monitor Immunotherapy with a Personalized Blood Test with Angel Rodriguez, Oncology Medical Director at Natera

Immunotherapy is a kind of treatment for cancer that changed the landscape of oncology. In this episode, we had a very insightful chat with Dr. Angel Rodríguez, Natera’s Oncology Medical Director. At the same time, he explains how immunotherapy works, what it entails, how patients can be treated, and the medical challenges around this.

With immunotherapy, doctors can choose a type of treatment that attacks cancer in a localized way instead of chemo or radiotherapy, which it’s more of a “shotgun approach.” Dr. Rodríguez shares how sometimes immunotherapy can come with more than one challenge, why it is not a standard treatment, and how Natera is innovating with blood tests to identify if there is any disease left in the body. The future of oncology lies ahead, and Natera is leading the way.

Tune in to this episode to listen to one of the best oncologists in the nation!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.